Abrar S,Ain NU,Liaqat H,Hussain S,Rasheed F,Riaz S .2019 .Distribution of bla CTX− M, bla TEM, bla SHV and bla OXA genes in Extended-spectrum-β-lactamaseproducing Clinical isolates: A three-year multi-center study from Lahore, Pakistan. Antimicrobial Resistance & Infection Control, 8(1) : 80.
Al-Badr A,Al-Shaikh G .2013 .Recurrent urinary tract infections management in women: a review. Sultan, 13(3) : 359.
Alqasim A,Abu Jaffal A,Alyousef A .2018 .Prevalence of Multidrug Resistance and ExtendedSpectrum β‐ Lactamase Carriage of Clinical Uropathogenic Escherichia coli Isolates in Riyadh, Saudi Arabia. 2018(1), : 3026851.
Azap K,Arslan H,Şerefhanoğlu K,Çolakoğlu Ş,Erdoğan H,Timurkaynak F,Senger S .2010 .Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clinical microbiology and infection, 16(2) : 147-151.
Bindayna M,Senok C,Jamsheer E .2009 .Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain. J. Infection and Public Health, 2(3) : 129-135.
Bonadio M,Meini M,Spitaleri P,Gigli C .2001 .Current microbiological and clinical aspects of urinary tract infections. European urology, 40(4) : 439-445.
Coque M,Baquero F,Canton R .2008 .Increasing prevalence of ESBLproducing Enterobacteriaceae in Europe. , 13(47) : 19044.
El Astal Y,Ramadan H Y .2008 .Occurrence of extended-spectrum beta-lactamases in isolates of Klebsiella pneumoniae and Escherichia coli. Int. J integr Bio, 2(2) : 122.
Harris N,Yin M,Jureen R,Chew J,Ali J,Paynter S,Tambyah A .2015 .Comparable outcomes for β- lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaximeresistant Escherichia coli or Klebsiella pneumoniae. Antimicrobial resistance and infection control, 4(1) : 14.
Hassan A,Jamal A,Kamal M .2011 .Occurrence of multidrug resistant and ESBL producing E. coli causing urinary tract infections. J. of Basic & Applied Sciences, 7(1) : .
Hsueh R,Ko C,Wu J,Lu J,Wang D,Wu Y,Teng J .2010 .Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010- update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan. J.Microbiology, Immunology and Infection, 43(5) : 452-455.
Marrs F,Zhang L,Foxman B .2005 .Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes. FEMS microbiology letters, 252(2) : 183-190.
Okeke N,Laxminarayan R,Bhutta A,Duse G,Jenkins P,O'Brien F,Klugman P F .2005 .Antimicrobial resistance in developing countries. Part I: recent trends and current status. The Lancet infectious diseases, 5(8) : 481-493.
Paterson L,Bonomo A .2005 .Extendedspectrum β-lactamases: a clinical update. Clinical microbiology reviews, 18(4) : 657-686.
Prestinaci F,Pezzotti P,Pantosti A,H. A .2018 .Escherichia coli in Iran: An Overview of Antibiotic Resistance: A Review Article. Iranian journal of public health, 47(1) : 1-318.
Ramírez-Castillo F,Moreno-Flores F,Avelar-González F,Márquez-Díaz F,Harel J,Guerrero-Barrera A .2018 .An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Annals of clinical microbiology and antimicrobials, 17(1) : 34.
Riaz S,Bashir M .2015 .Phenotypic and molecular characterization of plasmid-encoded extended spectrum beta-lactamases produced by Escherichia coli and Klebsiella spp from Lahore, Pakistan. Tropical J. Pharm. Research, 14(9) : 1597-1604.
Sharma A,Bhat G,Shenoy S .2007 .Virulence factors and drug resistance in Escherichia coli isolated from extraintestinal infections. Indian J. medical microbiology, 25(4) : 369-373.
Sharma A,Bhatta R,Shrestha J,Banjara M .2013 .Antimicrobial susceptibility pattern of Escherichia coli isolated from urinary tract infected patients attending Bir Hospital. Nepal J Sci Technol, 14(1) : 177-8.
Shaikh S,Fatima J,Shakil S,Rizvi D,Kamal M .2015 .Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J. biological sci, 22(1) : 90-101.
Singh M,Singh H .2014 .Comparative evaluation of six phenotypic methods for detecting extendedspectrum beta-lactamase-producing Enterobacteriaceae. The J. Infection in Developing Countries, 8(04) : 408-415.
Trevor A,Katzung B,Master B,Kruidering-Hall M,McGraw-Hill Medical M .2010 .Pharmacology examination & board review. , : .
Ullah F,Malik S,Ahmed J .2009 .Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. African J. Biotech, 8(16) : .
Wilson L,Gaido L. .2004 .Laboratory diagnosis of urinary tract infections in adult patients. Clinical infectious diseases, 38(8) : 1150-1158.
Nasser M,Palwe S,Bhargava N,Feuilloley G,Kharat S. .2020 .Retrospective analysis on antimicrobial resistance trends and prevalence of β-lactamases in Escherichia coli and ESKAPE pathogens isolated from Arabian patients during 2000- 2020. , 8(10) : 1626.
Moglad H ,Microbio Sudan. Intern. J. .2020 .Antibiotics profile, prevalence of extended-spectrum beta-lactamase (ESBL), and multidrug-resistant Enterobacteriaceae from different clinical samples in Khartoum State. , : .
Hashemizadeh Z,Mansouri S,Pahlavanzadeh F,MoronesRamírez R,Tabatabaeifar F,Motamedifar M,D M .2020 .Evaluation of chromosomally and acquired mechanisms of resistance to carbapenem antibiotics among clinical isolates of Pseudomonas aeruginosa in Kerman, Iran. Gene Reports, 21 : 100918.
Tasleem S,Moon S.,Alghamdi S,Ateeq R S,Salman M,Bantun M,F M .2022 .Presence of BlaPER-1 and BlaVEB-1 Beta-Lactamase Genes among Isolates of Pseudomonas Aeruginosa from Burn and Trauma Hospital Peshawar, Pakistan. J. Bioresource Management, 9(2) : 15.
Hariri S,Khan S,Biology Molecular .2023 .Physiology. , 15(1) : 259-265.
Shariati A,Arshadi M,Khosrojerdi M,Abedinzadeh M,Ganjalishahi M,Maleki A,Khoshnood S .2022 .The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Frontiers in public health, 10 : 1025633.